Back

Current status of antiarrhythmic therapy in atrial fibrillation

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Update on antiarrhythmic therapy Rhythm Control, Antiarrhythmic Drugs EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Associate Professor Babak Nazer

University of Washington, Seattle (United States of America)

3 More presentations in this session

Presentation thumbnail
Antiarrhythmic therapy in pregnancy
Doctor A. Perez-Silva (Concepcion, CL)
Slides Video
Presentation thumbnail
Promising electrical targets for novel antiarrhythmic strategies in atrial fibrillation
Professor N. Jost (Szeged, HU)
Slides Video
Presentation thumbnail
Targeting atrial myopathy: is this the future of pharmacological rhythm control in atrial fibrillation?
Professor B. Brundel (Amsterdam, NL)
Slides Video

Access the full session

Session thumbnail
Update on antiarrhythmic therapy
Video

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Session
Practical dilemmas in atrial fibrillation therapies
thumbnail
Congress Session
Scanning the horizon: trials that will improve care of atrial fibrillation patients
thumbnail
Congress Session
Treatment of atrial fibrillation: there is more than ablation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources